Aivot Labs Oy

Aivot Labs Oy, based in Helsinki, Finland, specializes in developing AI voice agents to enhance patient communication in healthcare, focusing on automating processes to improve efficiency and engagement within medical facilities. Founded in 2024, Aivot Labs Oy creates AI solutions specifically for healthcare communication. The company has engaged in one funding round and in April 2025 raised EUR 150,000 in pre-seed funding from investor Antler. The firm is headquartered in Helsinki, Finland.

Aivot Labs specializes in developing advanced AI voice agents that automate patient communication within healthcare settings. Their core offerings include clinical follow-up assistants, preventive and chronic care assistants, and dental booking assistants, all designed to streamline the patient interaction process from scheduling appointments to follow-up care. These AI agents are tailored to serve both public and private healthcare providers across a wide range of facilities, enhancing efficiency and patient engagement. Aivot's solutions are particularly prominent in the Nordic region and are integrated seamlessly with existing systems such as electronic health records (EHR), scheduling platforms, and customer relationship management (CRM) tools.

Their commitment to providing 24/7 availability ensures that patients receive timely responses, contributing to better service accessibility and overall patient satisfaction. Aivot Labs generates revenue primarily through a subscription-based model, where healthcare providers pay for access to their suite of AI communication tools. Clients engage with Aivot through direct partnerships, allowing for tailored implementation of the AI agents into their existing systems. The pricing structure is designed to accommodate various healthcare facilities, ensuring scalability as client needs evolve.

By leveraging their flagship products, such as the multilingual voice agents for clinical follow-ups and care management, Aivot Labs reinforces its position in the market, providing essential tools that optimize patient care while reducing the administrative burden for healthcare staff. Aivot Labs plans to leverage its recent funding of EUR 150,000 raised in April 2025 to enhance its product offerings and expand into new markets. Upcoming products focus on enhanced AI capabilities for patient interaction. The company aims to enter additional Nordic markets by the end of 2025, positioning itself to better serve healthcare providers in those regions.